Global Bulk API Market Growth (Status and Outlook) 2024-2030

Global Bulk API Market Growth (Status and Outlook) 2024-2030

Bulk APIs refer to traditional chemical APIs such as penicillin, vitamins, and hormones that are of large tonnage and do not involve patent issues. The characteristics of this product are large output, many manufacturing companies, fierce market competition, and low product price and added value.

The global Bulk API market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LPI (LP Information)' newest research report, the “Bulk API Industry Forecast” looks at past sales and reviews total world Bulk API sales in 2022, providing a comprehensive analysis by region and market sector of projected Bulk API sales for 2023 through 2029. With Bulk API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bulk API industry.

This Insight Report provides a comprehensive analysis of the global Bulk API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Bulk API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Bulk API market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bulk API and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bulk API.

United States market for Bulk API is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Bulk API is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Bulk API is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Bulk API players cover Mallinckrodt Pharmaceuticals, IOL, Granules India, BASF, Novacyl, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Bulk API market by product type, application, key players and key regions and countries.

Segmentation by Type:
Vitamins
Antibiotic
Antipyretic and Analgesic
Corticoids
Others

Segmentation by Application:
Prescription Drugs
OTC Drugs

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Segmentation by Type:
Vitamins
Antibiotic
Antipyretic and Analgesic
Corticoids
Others

Segmentation by Application:
Prescription Drugs
OTC Drugs

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Mallinckrodt Pharmaceuticals
IOL
Granules India
BASF
Novacyl
Sichuan Kelun Pharmaceutical
Shandong Lukang Pharmaceutical
CSPC Pharmaceutical
Harbin Pharmaceutical
North China Pharmaceutical
Shandong Xinhua Pharmaceutical
Northeast Pharmaceutical
United Laboratories
Apeloa Pharmaceutical
Zhejiang AngLiKang Pharmaceutical
Zhejiang Huahai Pharmaceutical
Zhejiang Tianyu Pharmaceutical
Shenzhen Hepalink Pharmaceutical

Please note: The report will take approximately 2 business days to prepare and deliver.